School of Life Sciences
   
   
  

PGR Symposium

Location
Medical School, Queen’s Medical Centre
Date(s)
Wednesday 11th (09:00) - Thursday 12th July 2018 (17:00)
Contact
For enquiries, or to attend, please email the PG Symposium Team
Description

Open to all School of Life Sciences postgraduate research students (PhD/MRes) and staff. An annual scientific event with research talks, poster sessions showcasing the science we do, prizes for the best oral and poster presentations, networking opportunities and free food. 

There will be three parallel sessions running each day for the student talks, plus poster sessions during lunch, all of which will be judged and prizes awarded. Attendees can choose which sessions to attend based on their research interests. There is a keynote speaker planned for Wednesday followed by a drinks reception.

Wednesday 11 and Thursday 12 July
Lecture theatre 1, 3 and 4, Medical School, Queen’s Medical Centre

Keynote talk

Genomics and Neurodegenerative, Disease

11 July, 4pm, lecture theatre 1, Medical School, Queen's Medical Centre

Presented by Professor John Hardy PhD, FRS. University College London, UK.

John Hardy is the Head of the Department of Molecular Neuroscience and Chair of Molecular Biology of Neurological Disease at the University College London Institute of Neurology. He was the first to discover a mutation in the amyloid gene encoding the amyloid precursor protein (APP) which plays a key role in neurodegeneration associated with Alzheimer’s disease.

His research interests are in the genetic analysis of disease. Historically, he has worked on the genetic analysis of Alzheimer's disease and other dementias and more recently, on Parkinson's disease and other movement disorders and on motor neuron disease.

His early studies were on Mendelian forms of disease, and these studies continue, but an increasing focus has been on the genetic analysis of complex traits related to disease. Additionally, this latter analysis has created an increasing interest in population genetics because the risk variants for human traits are likely to be different in different racial groups.  In all cases the intention is to develop an understanding of the underlying genetics of a disorder both in the understanding of disease mechanisms and to help in the search for treatments.

Among his honors and awards are the Peter Debje Prize, University of Limburg, Belgium, for Alzheimer’s Research in 1991; the IPSEN Prize for Research into Alzheimer's disease in 1992; the Potamkin Prize from the American Academy of Neurology, for Alzheimer’s Research in 1993; the Allied Signal Prize for Research into Aging and the MetLife Prize for Research into Alzheimer’s disease in 1995; the Kaul Prize for Research into Alzheimer’s disease in 2002; and the Anne Marie Oprecht International Prize for research in Parkinson’s disease in 2008. He is a member of the academy of Medical Sciences and Fellow of the Royal Society of London in 2009 and in 2010 was awarded an honorary Doctor of Science degree by the University of Newcastle and the Khalid Iqbal Award for Lifetime Achievement as well as The IFRAD Prize for Alzheimer’s Research in 2011.  In 2014 he was awarded The Dan David Prize endowed by the Dan David Foundation, headquartered at Tel Aviv University;  the Thudichum Medal from the Biochemical Society and is the recipient of the 3rd Lord Brain Memorial Medal.  Recently, he was awarded the Robert A. Pritzker Prize by the Michael J. Fox Foundation. During 2015 he was awarded the Piepenbrock-DZNE Award, and the Breakthrough Prize in Life Sciences followed in 2016 by the Helis Prize.  In 2018 he was jointly awarded the Brain Prize from Lundbeck.

School of Life Sciences

University of Nottingham
Medical School
Queen's Medical Centre
Nottingham NG7 2UH

Contact us